Skip to main content

Table 6 Risks for admission to the ICU in immunosuppressed patients with influenza infections in logistics analyses

From: Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015–2020 influenza seasons

Variables

Odds Ratio

(95% CI)

 

P

Univariate analysis

Organ transplantation

4.00

1.33

12.03

0.014

Diabetes

4.94

1.37

17.80

0.015

Use of corticosteroids in the preceding 3 months

3.32

1.12

9.87

0.031

Neuraminidase inhibitor use before admission

4.94

1.22

20.08

0.025

Dyspnoea

11.08

2.80

43.93

0.001

Coinfection with other pathogens

8.57

2.69

27.32

0.000

Complications

7.85

2.08

29.62

0.002

No antiviral treatment within 48 h

5.94

1.84

19.15

0.000

Multivariate logistic regression analysis

Dyspnoea

32.33

2.07

504.56

0.013

Coinfection with other pathogens

60.65

3.09

1188.84

0.007

No antiviral treatment within 48 h

16.28

1.11

238.37

0.042